Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

Somatostatin receptors are a pivotal target for treatment of pancreatic neuroendocrine tumors (pNET), either with somatostatin analogues (SSA) or radiolabeled SSA. The highest affinity target for the most commonly used SSA is the somatostatin receptor type 2 (sst(2)). An important factor that may co...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Veenstra, Marije J., van Koetsveld, Peter M., Dogan, Fadime, Farrell, William E., Feelders, Richard A., Lamberts, Steven W.J., de Herder, Wouter W., Vitale, Giovanni, Hofland, Leo J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2016
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871078/
https://ncbi.nlm.nih.gov/pubmed/29599907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9462
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg